Characterization of molecular mechanisms underlying the axonal Charcot-Marie-Tooth neuropathy caused by MORC2 mutations
Language English Country England, Great Britain Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
30624633
DOI
10.1093/hmg/ddz006
PII: 5280748
Knihovny.cz E-resources
- MeSH
- Axons metabolism pathology MeSH
- Charcot-Marie-Tooth Disease genetics pathology MeSH
- Embryonic Stem Cells metabolism MeSH
- Fibroblasts metabolism pathology MeSH
- Rats MeSH
- Humans MeSH
- Mutation genetics MeSH
- Neural Stem Cells MeSH
- Sensory Receptor Cells metabolism pathology MeSH
- Gene Expression Regulation genetics MeSH
- Transcription Factors genetics MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- MORC2 protein, human MeSH Browser
- Transcription Factors MeSH
Mutations in MORC2 lead to an axonal form of Charcot-Marie-Tooth (CMT) neuropathy type 2Z. To date, 31 families have been described with mutations in MORC2, indicating that this gene is frequently involved in axonal CMT cases. While the genetic data clearly establish the causative role of MORC2 in CMT2Z, the impact of its mutations on neuronal biology and their phenotypic consequences in patients remains to be clarified. We show that the full-length form of MORC2 is highly expressed in both embryonic and adult human neural tissues and that Morc2 expression is dynamically regulated in both the developing and the maturing murine nervous system. To determine the effect of the most common MORC2 mutations, p.S87L and p.R252W, we used several in vitro cell culture paradigms. Both mutations induced transcriptional changes in patient-derived fibroblasts and when expressed in rodent sensory neurons. These changes were more pronounced and accompanied by abnormal axonal morphology, in neurons expressing the MORC2 p.S87L mutation, which is associated with a more severe clinical phenotype. These data provide insight into the neuronal specificity of the mutated MORC2-mediated phenotype and highlight the importance of neuronal cell models to study the pathophysiology of CMT2Z.
Department of Clinical Neuroscience Karolinska Institutet 17165 Stockholm Sweden
Department of Medicine University of Valencia Valencia Spain
Department of Neuroscience Karolinska Institutet Stockholm Sweden
Department of Pediatric Neurology Hospital Universitario La Paz Madrid Spain
Molecular Medicine Laboratory Concord Hospital Concord NSW Australia
Northcott Neuroscience Laboratory ANZAC Research Institute Concord NSW Australia
Sydney Medical School University of Sydney Sydney NSW Australia
The R and D Unit Stiftelsen Stockholms Sjukhemm 14152 Sweden
Unit of Bioinformatics and Biostatistics Centro de Investigación Príncipe Felipe Valencia Spain
References provided by Crossref.org